ABIVAX Société Anonyme (AAVXF)
OTCMKTS · Delayed Price · Currency is USD
86.10
0.00 (0.00%)
Sep 18, 2025, 8:00 PM EDT
ABIVAX Société Anonyme Revenue
ABIVAX Société Anonyme had revenue of 1.05M EUR in the quarter ending June 30, 2025, a decrease of -81.34%. This brings the company's revenue in the last twelve months to 6.02M, down -33.90% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.
Revenue (ttm)
6.02M EUR
Revenue Growth
-33.90%
P/S Ratio
872.64
Revenue / Employee
87.29K EUR
Employees
69
Market Cap
6.17B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.79M | 6.22M | 135.94% |
Dec 31, 2023 | 4.57M | 69.00K | 1.53% |
Dec 31, 2022 | 4.51M | 302.00K | 7.19% |
Dec 31, 2021 | 4.20M | 4.19M | 29,921.43% |
Dec 31, 2020 | 14.00K | 21.00K | -300.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 2.12M |
Elite Pharmaceuticals | 105.45M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |
ABIVAX Société Anonyme News
- 10 days ago - Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - GlobeNewsWire
- 13 days ago - BTIG Reiterates Buy Rating on Abivax (ABVX) with $112 Price Target | ABVX Stock News - GuruFocus
- 14 days ago - Abivax SA (ABVX) Reports First Half 2025 Financial Results | ABVX stock news - GuruFocus
- 14 days ago - Abivax Presents First Half 2025 Financial Results - GlobeNewsWire
- 17 days ago - Abivax (ABVX) Gains on Takeover Speculation - GuruFocus
- 17 days ago - Abivax jumps amid takeover speculation - Seeking Alpha
- 22 days ago - Abivax (ABVX) Surges Following Positive Trial Data, Boosts Hedge Funds - GuruFocus
- 22 days ago - Abivax’s 580% surge hands biotech hedge funds a rare 2025 win - Seeking Alpha